Clinical Trial Update: Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating short incubation methyl aminolevulinate photodynamic therapy without occlusion for actinic keratosis; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Methyl aminolevulinate (methyl aminolevulinate)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2011-02-17